| Price | $0.976 on 31-08-2026 at 04:45:12 |
|---|---|
| Change | $0.00 0% |
| Buy | $0.98 |
| Sell | $0.978 |
| Last Trade: | Buy 100,357.00 at $0.98023 |
| Day's Volume: | 0 |
| Last Close: | $0.976 |
| Open: | $0.00 |
| ISIN: | GB00BDGKMY29 |
| Day's Range | $0.00 - $0.00 |
| 52wk Range: | $0.876 - $1.00 |
| Market Capitalisation: | $1.10b |
| VWAP: | $0.00 |
| Shares in Issue: | 1.12b |
Sector: Closed End Investments
Biopharma Cred. (BPCR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100,357 | $0.98023 | Suspected BUY Trade |
16:41:52 - 28-Aug-26 |
| Sell* | 5,205 | $0.976 | Uncrossing Trade |
16:35:24 - 28-Aug-26 |
| Buy* | 1 | $0.98 | SI Trade |
16:29:28 - 28-Aug-26 |
| Buy* | 16 | $0.98 | SI Trade |
16:29:28 - 28-Aug-26 |
| Sell* | 1 | $0.978 | SI Trade |
15:48:00 - 28-Aug-26 |
| Buy* | 1,950 | $0.98 | Automatic Execution |
15:48:00 - 28-Aug-26 |
| Buy* | 4 | $0.98 | SI Trade |
15:39:14 - 28-Aug-26 |
| Buy* | 8 | $0.98 | SI Trade |
15:39:14 - 28-Aug-26 |
| Buy* | 10 | $0.98 | SI Trade |
15:39:14 - 28-Aug-26 |
| Buy* | 29,610 | $0.98102 | Ordinary |
15:21:52 - 28-Aug-26 |
Biopharma Cred. (BPCR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Aug 2026 10:00 am | RNS | Notice of Half Year Results |
| 24th Aug 2026 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 20th Aug 2026 7:00 am | RNS | Completion of Lumira Sale |
| 3rd Aug 2026 5:36 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 5:14 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 15th Jul 2026 7:00 am | RNS | NEW INVESTMENT IN KESTRA MEDICAL |
| 14th Jul 2026 7:00 am | RNS | UPDATE ON ARCHIMED ESPERION ACQUISITION |
| 19th Jun 2026 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 19th Jun 2026 10:47 am | RNS | Dividend Declaration |
